Delivery Order SPE2DB20D3101-SPE2DB23FRTD6

Award Date 7/31/23
Potential Completion Date 8/1/23
Potential Value $199
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $1,971.77 firm fixed price delivery order to Amerisourcebergen Drug Corporation for clindamycin phosphate topical gel. The prime contractor will deliver 60 grams of the 1% clindamycin phosphate gel to a location in Conshohocken, Pennsylvania by August 9, 2023, in support of the Defense Logistics Agency's medical supply needs. No major subcontractors or set aside designations were indicated. The delivery order was awarded under an existing DLA medical...
The Defense Logistics Agency awarded a $217 firm fixed price delivery order to Amerisourcebergen Drug Corporation for clindamycin phosphate 1% gel. The order is for 30 grams of the topical antibiotic under contract number 4561585397. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between July 24-25, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency manages the global supply chain for...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $471 to Amerisourcebergen Drug Corporation for 30-gram tubes of 1% clindamycin gel. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical product from its Conshohocken, Pennsylvania facility on behalf of DLA between August 10-11, 2023. No subcontractors or set aside designations were indicated. This order is consistent with DLA's mission to provide medical supplies...
The Defense Logistics Agency awarded a $391,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561401258 clindamycin phosphate 1% gel 30gm. The prime contractor will deliver the pharmaceutical product from its Conshohocken, Pennsylvania facility to the Defense Logistics Agency by July 5, 2023 to support Department of Defense medical supply needs. No major subcontractors or set aside designations were indicated. This delivery order was issued against an existing DLA...
The Defense Logistics Agency awarded a $3,538 delivery order to Amerisourcebergen Drug Corporation for clindamycin phosphate 1% gel. The firm fixed price order is for 75ml of the topical antibiotic medication and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by July 28, 2023. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen supports the DLA's mission to provide logistics support for all military services and several federal...
The Defense Logistics Agency awarded a $1,829.70 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 60 grams of the antibiotic clindamycin phosphate gel 1%. The single day contract has a period of performance from August 3 to August 4, 2023, with all work taking place in Conshohocken, Pennsylvania. DLA manages the Department of Defense's global supply chain and this small contract for a common antibiotic supports its medical supply procurement programs. No subcontractors...
The Defense Logistics Agency awarded a $100,350 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30-gram tubes of 1% clindamycin gel. The prime contractor will deliver the pharmaceutical to a facility in Conshohocken, Pennsylvania by June 30, 2023 in support of the Defense Department's medical supply needs. No subcontractors or set aside designations were indicated. The Defense Logistics Agency manages the global supply chain for the U.S. military and this order falls...
The Defense Logistics Agency awarded a $804.66 delivery order contract to Amerisourcebergen Drug Corporation for the supply of 30-gram tubes of 1% clindamycin gel. The contract has a firm fixed price and will be performed by Amerisourcebergen in Conshohocken, Pennsylvania between September 1-5, 2023. The Defense Logistics Agency manages the Department of Defense's global supply chain and supports military services and combatant commands worldwide. This delivery order for an antibiotic gel is...
The Defense Logistics Agency awarded a $7,131 firm fixed price delivery order to Amerisourcebergen Drug Corporation for clindamycin phosphate topical gel. The order is for 30-gram containers of the 1% concentration gel to be delivered to a facility in Conshohocken, Pennsylvania by July 31, 2023. Amerisourcebergen will provide the pharmaceutical product to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were specified in the award...
The Defense Logistics Agency awarded a $1,974.57 firm fixed price delivery order to Amerisourcebergen Drug Corp for 4561490261 clindamycin phosphate 1% gel 30gm. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested pharmaceutical products to the location of performance in Conshohocken, Pennsylvania by July 14, 2023 under the terms of the contract. The Defense Logistics Agency is the funding agency for this delivery order placed against an existing Amerisourcebergen...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRTD6
    Delivery Order

The Defense Logistics Agency awarded a $198,960 delivery order to Amerisourcebergen Drug Corporation for clindamycin phosphate 1% gel. The firm fixed price order is for 30-gram tubes of the topical antibiotic to support DLA pharmaceutical needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from July 31 to August 1, 2023. No set aside designation or subcontractors were identified. This order was issued against an existing DLA pharmaceutical supply vehicle to fulfill immediate product requirements.

Generated 12/22/23, 8:11 PM